Ta-Wei Guu 谷大為

Academic Appointments

  • Head of Teaching and Research Department, Beigang Affiliated Hospital of China Medical University Hospital

          中國醫藥大學北港附設醫院教研部教學組長

  • Attending Physician, Department of Physical and Mental Medicine, Affiliated Hospital of Beigang, China Medical University Hospital

          中國醫藥大學北港附設醫院身心內科主治醫師

  • Attending physician, Sleep Center, Affiliated Hospital of China Medical University Hospital

         中國醫藥大學附設醫院睡眠中心兼任主治醫師

  • Attending physician, Department of Psychiatry, Affiliated Hospital of China Medical University Hospital

         中國醫藥大學附設醫院精神醫學部兼任主治醫師

Education

  •  Department of Medicine, National Defense Medical College (won the "Honorary Student Award")

            國防醫學院醫學系畢業(獲當年度「榮譽學生獎」)

  • University of Stanford Sleep Medicine Center

          美國史丹佛大學睡眠醫學中心進修

  • Swiss University of Standardization Physiology Research Exchange Student (laborator Prof. Paolo Meda, M.D., Ph.D.) Project name: Biological function of connexin. [World Medical Student Union Awards]

          瑞士日內瓦大學生理學科研究交換學生(實驗室主持人Prof. Paolo Meda, M.D., Ph.D.)計畫名稱: The biological  functions of connexion proteins. [世界醫學生聯盟獎助]

Professional Experiences

  • Resident and Chief Physician, Department of Psychiatry, Affiliated Hospital of China Medical University Hospital

         中國醫藥大學附設醫院精神醫學部住院醫師、總醫師

  • Resident, General Department, National Taiwan University Hospital 

          國立台灣大學附設醫院一般科住院醫師

  • Intern, Kaohsiung Rongmin General Hospital

          高雄榮民總醫院實習醫師

  • World Vision Thailand Branch Regional Development Project-Intern, Mae-Fah-Luang Hospital, Chiang Rai Province, Thailand

           世界展望會泰國分會區域發展計畫-泰國清萊省泰后醫院(Mae-Fah-LuangHospital)實習醫師[中華民國教育部青年發展署實習青年計畫獎助]

Research Interests

Depression, cognitive impairment (dementia), geriatric medicine, sleep medicine, nutritional psychiatry, autoimmunity 

(憂)鬱症、認知障礙症(失智症)、老人醫學、睡眠醫學、營養精神醫學、自體免疫學

Publications

  1. Sun, C., Chiu, W., Chen, P., Chang, H., Guu, T., & Shityakov, S. et al. (2020). Depression-free after Interferon-α Exposure Indicates Less Incidence of Depressive disorder: A Longitudinal Study in Taiwan. Brain, Behavior, And Immunity. https://doi.org/10.1016/j.bbi.2020.05.044
  2. Guu, T., Tsai, S. & Su K. (2020). Autoimmune Psychosis in Taiwan: a case report and review of literature. Brain, Behavior, & Immunity - Health, 100055, doi: 10.1016/j.bbih.2020.100055
  3. Guu, T., Mischoulon, D., Sarris, J., Hibbeln, J., McNamara, R., & Hamazaki, K. et al. (2020). A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. Journal of Affective Disorders, 265, 233-238. doi: 10.1016/j.jad.2020.01.050
  4. Guu, T., & Su, K. (2019). Reply to the Letter to the Editor: Response to “International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder” by Guu et al. (2019). Psychotherapy And Psychosomatics, 89(1), 49-49. doi: 10.1159/000504232
  5. Guu, T., Mischoulon, D., Sarris, J., Hibbeln, J., McNamara, R., & Hamazaki, K. et al. (2019). International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychotherapy And Psychosomatics, 88(5), 263-273. doi: 10.1159/000502652
  6. Satyanarayanan, S., Chien, Y., Chang, J., Huang, S., Guu, T., Su, H., & Su, K. (2019). Melatonergic agonist regulates circadian clock genes and peripheral inflammatory and neuroplasticity markers in patients with depression and anxiety. Brain, Behavior, And Immunity. doi: 10.1016/j.bbi.2019.03.003
  7. Chang, J., Guu, T., Chen, Y., Gałecki, P., Walczewska, A., & Su, K. (2018). BanI polymorphism of cytosolic phospholipase A2 gene and somatic symptoms in medication-free acute depressed patients. Prostaglandins, Leukotrienes And Essential Fatty Acids, 136, 111-115. doi: 10.1016/j.plefa.2017.01.001
  8. Su, K., Yang, H., Chang, J., Shih, Y., Guu, T., & Kumaran, S. et al. (2018). Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients. Progress In Neuro-Psychopharmacology And Biological Psychiatry, 80, 227-233. doi: 10.1016/j.pnpbp.2017.06.020
  9. Nishi, D., Su, K., Usuda, K., Chang, J., Chiang, Y., & Guu, T. et al. (2017). Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study. Nutritional Neuroscience, 22(1), 63-71. doi: 10.1080/1028415x.2017.1354540
  10. Nishi, D., Su, K., Usuda, K., Chiang, Y., Guu, T., & Hamazaki, K. et al. (2016). Omega-3 fatty acid supplementation for expectant mothers with depressive symptoms in Japan and Taiwan: An open-label trial. Psychiatry And Clinical Neurosciences, 70(6), 253-254. doi: 10.1111/pcn.12388

Contact

d66753@mail.bh.cmu.edu.tw